Oncología Digestiva (GIODO)

Artículos Científicos

• Arias Ron D, Areses Manrique MC, Mosquera Martínez J, García González J, Afonso Afonso FJ, Lázaro Quintela M, Fernández Núñez N, Azpitarte Raposeiras C, Amenedo Gancedo M, Santomé Couto L, García Campelo MR, Muñoz Iglesias J, Ruiz Bañobre J, Vilchez Simo R, Casal Rubio J, Campos Balea B, Carou Frieiro I, Alonso-Jaudenes Curbera G, Anido Herranz U, García Mata J, Fírvida Pérez JL. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group. J Geriatr Oncol. 2021 Apr;12(3):410–5. PMID: 33357975. DOI: 10.1016/j.jgo.2020.11.010. http://www.ncbi.nlm.nih.gov/pubmed/33357975 +Pubmed +DOI
• Chandrapalan S, Bosch S, Cubiella J, Guardiola J, Kimani P, Mulder C, Persaud K, de Meij TGJ, Altomare DF, Brenner H, de Boer NKH, Ricciardiello L, Arasaradnam RP. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer. Aliment Pharmacol Ther. 2021;54(1):14–23. PMID: 34004036. DOI: 10.1111/apt.16405. http://www.ncbi.nlm.nih.gov/pubmed/34004036 +Pubmed +DOI
• Chaparro M, Garre A, Núñez Ortiz A, Diz-Lois Palomares MT, Rodríguez C, Riestra S, Vela M, Benítez JM, Fernández Salgado E, Sánchez Rodríguez E, Hernández V, Ferreiro-Iglesias R, Ponferrada Díaz Á, Barrio J, Huguet JM, Sicilia B, Martín-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernández-Salazar L, Varela Trastoy P, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollón F, Guerra Del Río E, Piñero C, Casanova MJ, Spicakova K, Ortiz de Zarate J, Torrella Cortés E, Gutiérrez A, Alonso-Galán H, Hernández-Martínez Á, Marrero JM, Lorente Poyatos R, Calafat M, Martí Romero L, Robledo P, Bosch O, Jiménez N, Esteve Comas M, Duque JM, Fuentes Coronel AM, Josefa Sampedro M, Sesé Abizanda E, Herreros Martínez B, Pozzati L, Fernández Rosáenz H, Crespo Suarez B, López Serrano P, Lucendo AJ, Muñoz Vicente M, Bermejo F, Ramírez Palanca JJ, Menacho M, Carmona A, Camargo R, Torra Alsina S, Maroto N, Nerín de la Puerta J, Castro E, Marín-Jiménez I, Bot +Pubmed +DOI
• Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X, en representación de la Asociación Española de Gastroenterología la SE de ED y la SE de AP. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol. 2021 Jan;44(1):67–86. PMID: 33252332. DOI: 10.1016/j.gastrohep.2020.08.004. http://www.ncbi.nlm.nih.gov/pubmed/33252332 +Pubmed +DOI
• Dolz Abadía C, Pons Beltrán V, Sánchez Hernández E, Sánchez Ocaña R, Gornals J, Foruny JR, Vila J, González-Huix F. CHOLANGIOPANCREATOSCOPY. WORKING PROTOCOL. SEED Recommendations. Rev Esp Enferm Dig. 2021 Mar;113(3):207–14. PMID: 33267604. DOI: 10.17235/reed.2020.7531/2020. http://www.ncbi.nlm.nih.gov/pubmed/33267604 +Pubmed +DOI
• Fernández Montes A, Martinez-Lago N, de la Cámara Gomez J, Brozos Vázquez EM, Candamio Folgar S, Carmona Campos M, Cousillas Castiñeiras A, Covela Rúa M, Gallardo Martín E, González Villarroel P, Graña Suarez B, Jorge Fernández M, Pellón Augusto ML, Quintero Aldana G, Romero Reinoso C, Salgado Fernández M, Vázquez Rivera F, Ayuso Álvarez A, Culqui DR, Méndez Méndez JC, RIGhT-Sens Working Group. Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method. Healthc (Basel, Switzerland). 2021 Jun;9(6):665. PMID: 34205026. DOI: 10.3390/healthcare9060665. http://www.ncbi.nlm.nih.gov/pubmed/34205026 +Pubmed +DOI
• Fernández-Esparrach G, Marín-Gabriel JC, Díez Redondo P, Núñez H, Rodríguez de Santiago E, Rosón P, Calvet X, Cuatrecasas M, Cubiella J, Moreira L, Pardo López ML, Pérez Aisa Á, Sanz Anquela JM, en representación de la Asociación Española de Gastroenterología la SE de ED y la SE de AP. Quality in diagnostic upper gastrointestinal endoscopy for the detection and surveillance of gastric cancer precursor lesions: Position paper of AEG, SEED and SEAP. Gastroenterol Hepatol. 2021;44(6):448–64. PMID: 33609597. DOI: 10.1016/j.gastrohep.2021.01.002. http://www.ncbi.nlm.nih.gov/pubmed/33609597 +Pubmed +DOI
• Gallardo-Gómez M, De Chiara L, Álvarez-Chaver P, Cubiella J. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Rev Anticancer Ther. 2021 Jul;21(7):723–38. PMID: 33507120. DOI: 10.1080/14737140.2021.1882858. http://www.ncbi.nlm.nih.gov/pubmed/33507120 +Pubmed +DOI
• Jimenez-Fonseca P, Carmona-Bayonas A, Martinez-Torron A, Alsina M, Custodio A, Serra O, Cacho Lavin D, Limón ML, Sauri T, López F, Visa L, Granja M, Martínez Lago N, Arrazubi V, Vidal Tocino R, Hernandez R, Aguado G, Cano JM, Martín Carnicero A, Mangas M, Pimentel P, Fernández Montes A, Macias Declara I, Longo F, Ramchandani A, Martín Richard M, Hurtado A, Azkarate A, Hernández Pérez C, Serrano R, Gallego J, AGAMENON-SEOM study group. External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry. Ther Adv Med Oncol. 2021;13:17588359211019672. PMID: 34211587. DOI: 10.1177/17588359211019672. http://www.ncbi.nlm.nih.gov/pubmed/34211587 +Pubmed +DOI
• Lorenzo-Pouso AI, Castelo-Baz P, Rodriguez-Zorrilla S, Pérez-Sayáns M, Vega P. Association between periodontal disease and inflammatory bowel disease: a systematic review and meta-analysis. Acta Odontol Scand. 2021 Jul;79(5):344–53. PMID: 33370548. DOI: 10.1080/00016357.2020.1859132. http://www.ncbi.nlm.nih.gov/pubmed/33370548 +Pubmed +DOI
• Luque R, Benavides M, Del Barco S, Egaña L, García-Gómez J, Martínez-García M, Pérez-Segura P, Pineda E, Sepúlveda JM, Vieito M. SEOM clinical guideline for management of adult medulloblastoma (2020). Clin Transl Oncol. 2021 May;23(5):940–7. PMID: 33792841. DOI: 10.1007/s12094-021-02581-1. http://www.ncbi.nlm.nih.gov/pubmed/33792841 +Pubmed +DOI
• Peña-Rey I, Almazán R, Rodríguez-Camacho E, Cubiella J, Grupo de Trabajo del Programa de Detección Precoz de Cáncer Colorrectal de Galicia (Eloy Sanchez; Juan Turnes; Victoria Álvarez; J Ignacio Rodríguez Prada). Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results. Rev Esp Enferm Dig. 2021;113(2):119–21. PMID: 33393333. DOI: 10.17235/reed.2020.7647/2020. http://www.ncbi.nlm.nih.gov/pubmed/33393333 +Pubmed +DOI
• Pin-Vieito N, García Nimo L, Bujanda L, Román Alonso B, Gutierrez-Stampa MÁ, Aguilar-Gama V, Portillo I, Cubiella J. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study. United Eur Gastroenterol J. 2021 Aug;9(2):256–67. PMID: 32778002. DOI: 10.1177/2050640620949714. http://www.ncbi.nlm.nih.gov/pubmed/32778002 +Pubmed +DOI
• Regueiro C, Almazán R, Portillo I, Besó M, Tourne-Garcia C, Rodríguez-Camacho E, Ono A, Gómez-Amorín Á, Cubiella J. Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol. Diagnostics. 2021 Aug;11(9):1520. DOI: 10.3390/diagnostics11091520. https://www.mdpi.com/2075-4418/11/9/1520 +DOI
• Soares de Lima Y, Arnau-Collell C, Díaz-Gay M, Bonjoch L, Franch-Expósito S, Muñoz J, Moreira L, Ocaña T, Cuatrecasas M, Herrera-Pariente C, Carballal S, Moreno L, Díaz de Bustamante A, Castells A, Bujanda L, Cubiella J, Rodríguez-Alcalde D, Balaguer F, Castellví-Bel S. Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome. Cancers (Basel). 2021 Feb;13(4):929. PMID: 33672345. DOI: 10.3390/cancers13040929. http://www.ncbi.nlm.nih.gov/pubmed/33672345 +Pubmed +DOI
• Vera R, Salgado M, Safont MJ, Gallego J, González E, Élez E, Aranda E. Controversies in the treatment of RAS wild-type metastatic colorectal cancer. Clin Transl Oncol. 2021 Apr;23(4):827–39. PMID: 32789773. DOI: 10.1007/s12094-020-02475-8. http://www.ncbi.nlm.nih.gov/pubmed/32789773 +Pubmed +DOI

Artículos Científicos

• Alustiza M, Hernández-Illán E, Juárez M, Giner-Calabuig M, Mira C, Martínez-Roca A, Bujanda L, Rodríguez-Moranta F, Cubiella J, De-Castro L, Marín-Gabriel J-C, Herreros-de-Tejada A, Fernández-Bañares F, Nicolás-Pérez D, Giménez P, Martínez-Cardona C, Francés R, Murcia O, Jover R. Increased Th17-Related Cytokine Serum Levels in Patients With Multiple Polyps of Unexplained Origin. Clin Transl Gastroenterol. 2020;11(3):e00143. PMID: 32352715. DOI: 10.14309/ctg.0000000000000143. http://www.ncbi.nlm.nih.gov/pubmed/32352715 +Pubmed +DOI
• Arias Ron D, Labandeira CM, Cameselle García S, García Mata J, Salgado Fernández M. Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report. Case Rep Oncol. 2020;13(1):69–75. PMID: 32110222. DOI: 10.1159/000505237. http://www.ncbi.nlm.nih.gov/pubmed/32110222 +Pubmed +DOI
• Arnau-Collell C, Soares de Lima Y, Díaz-Gay M, Muñoz J, Carballal S, Bonjoch L, Moreira L, Lozano JJ, Ocaña T, Cuatrecasas M, Díaz de Bustamante A, Castells A, Capellà G, Bujanda L, Cubiella J, Rodríguez-Alcalde D, Balaguer F, Ruiz-Ponte C, Valle L, Moreno V, Castellvi-Bel S. Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility. J Med Genet. 2020;57(10):677–82. PMID: 32170005. DOI: 10.1136/jmedgenet-2019-106374. http://www.ncbi.nlm.nih.gov/pubmed/32170005 +Pubmed +DOI
• Bermejo de Las Heras B, Cortes Ramon Y Cajal J, Galve Calvo E, de la Haba Rodriguez J, Garcia Mata J, Moreno Anton F, Pelaez Fernandez I, Rodriguez-Lescure A, Rodriguez Sanchez CA, Ruiz-Borrego M, Remak E, Barra M, Rivero M, Soto Alvarez J. The economic burden of metastatic breast cancer in Spain. Eur J Hosp Pharm Sci Pract. 2020;27(1):19–24. PMID: 32064084. DOI: 10.1136/ejhpharm-2017-001453. http://www.ncbi.nlm.nih.gov/pubmed/32064084 +Pubmed +DOI
• Botana-Rial M, Vázquez-Iglesias L, Casado-Rey P, Cadena MP de la, Andrade-Olivié MA, Abal-Arca J, García-Nimo L, Ferreiro-Fernández L, Valdés-Cuadrado L, San-José ME, Rodríguez-Berrocal FJ, Fernández-Villar A. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial. Sci Rep. 2020;10(1):5679. PMID: 32231227. DOI: 10.1038/s41598-020-62388-y. http://www.ncbi.nlm.nih.gov/pubmed/32231227 +Pubmed +DOI
• Clos-Garcia M, Garcia K, Alonso C, Iruarrizaga-Lejarreta M, D´Amato M, Crespo A, Iglesias A, Cubiella J, Bujanda L, Falcón-Pérez JM. Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer. Cancers (Basel). 2020 May;12(5):1142. PMID: 32370168. DOI: 10.3390/cancers12051142. http://www.ncbi.nlm.nih.gov/pubmed/32370168 +Pubmed +DOI
• Cubiella J, González A, Almazán R, Rodríguez-Camacho E, Fontenla Rodiles J, Domínguez Ferreiro C, Tejido Sandoval C, Sánchez Gómez C, de Vicente Bielza N, Lorenzo IP-R, Zubizarreta R. pT1 Colorectal Cancer Detected in a Colorectal Cancer Mass Screening Program: Treatment and Factors Associated with Residual and Extraluminal Disease. Cancers (Basel). 2020 Sep;12(9):2530. PMID: 32899974. DOI: 10.3390/cancers12092530. http://www.ncbi.nlm.nih.gov/pubmed/32899974 +Pubmed +DOI
• Cubiella J. Not so FAST. Commentary on the article “Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study”. BMC Gastroenterol. 2020 Jul;20(1):231. PMID: 32690047. DOI: 10.1186/s12876-020-01322-y. http://www.ncbi.nlm.nih.gov/pubmed/32690047 +Pubmed +DOI
• Fernandez Montes A, Vazquez Rivera F, Martinez Lago N, Covela Rúa M, Cousillas Castiñeiras A, Gonzalez Villarroel P, de la Cámara Gómez J, Méndez Méndez JC, Salgado Fernández M, Candamio Folgar S, Reboredo López M, Carmona Campos M, Gallardo Martín E, Jorge Fernández M, Pellón Augusto ML, París Bouzas L, García Gómez J. Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram. Clin Transl Oncol. 2020 Mar;22(3):351–9. PMID: 31073972. DOI: 10.1007/s12094-019-02130-x. http://www.ncbi.nlm.nih.gov/pubmed/31073972 +Pubmed +DOI
• García-González J, Ruiz-Bañobre J, Afonso-Afonso FJ, Amenedo-Gancedo M, Areses-Manrique MDC, Campos-Balea B, Casal-Rubio J, Fernández-Núñez N, Fírvida Pérez JL, Lázaro-Quintela M, Pérez Parente D, Crama L, Ruiz-Gracia P, Santomé-Couto L, León-Mateos L. PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis. J Clin Med. 2020 Jul;9(7):2093. PMID: 32635291. DOI: 10.3390/jcm9072093. http://www.ncbi.nlm.nih.gov/pubmed/32635291 +Pubmed +DOI
• González-Del-Alba A, Arranz JÁ, Bellmunt J, Maroto JP, Fernández-Calvo O, Valderrama BP, González-Billalabeitia E, Méndez-Vidal MJ, Cassinello J, Romero-Laorden N, Climent MÁ, Puente J, Peláez I, Lázaro-Quintela M, Gallardo E, Suárez C. Latest progress in molecular biology and treatment in genitourinary tumours. Clin Transl Oncol. 2020 Dec;22(12):2175–95. PMID: 32440915. DOI: 10.1007/s12094-020-02373-z. http://www.ncbi.nlm.nih.gov/pubmed/32440915 +Pubmed +DOI
• Gutierrez-Stampa MA, Aguilar V, Sarasqueta C, Cubiella J, Portillo I, Bujanda L. Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test. Cancers (Basel). 2020 Aug;12(9):2412. PMID: 32854370. DOI: 10.3390/cancers12092412. http://www.ncbi.nlm.nih.gov/pubmed/32854370 +Pubmed +DOI
• Gutierrez-Stampa MA, Aguilar V, Sarasqueta C, Cubiella J, Portillo I, Bujanda L. Impact of the faecal immunochemical test on colorectal cancer survival. BMC Cancer. 2020 Jul;20(1):616. PMID: 32611328. DOI: 10.1186/s12885-020-07074-y. http://www.ncbi.nlm.nih.gov/pubmed/32611328 +Pubmed +DOI
• Mangas-Sanjuan C, Santana E, Cubiella J, Rodríguez-Camacho E, Seoane A, Alvarez-Gonzalez MA, Suárez A, Álvarez-García V, González N, Luè A, Cid-Gomez L, Ponce M, Bujanda L, Portillo I, Pellisé M, Díez-Redondo P, Herráiz M, Ono A, Pizarro Á, Zapater P, Jover R, QUALISCOPIA Study Investigators. Variation in Colonoscopy Performance Measures According to Procedure Indication. Clin Gastroenterol Hepatol. 2020 May;18(5):1216-1223.e2. PMID: 31446179. DOI: 10.1016/j.cgh.2019.08.035. http://www.ncbi.nlm.nih.gov/pubmed/31446179 +Pubmed +DOI
• Méndez Méndez JC, Salgado Fernández M, de la Cámara Gómez J, Pellón Augusto ML, Covela Rua M, Quintero Aldana G, Fernández Montes A, Reboredo López M, Valladares Ayerbes M, Jorge Fernández M, González Villarroel P, Romero Reinoso C, Ramos Vázquez M, Galician Research Group on Digestive Tumours (GITuD). First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study. J Geriatr Oncol. 2020;11(8):1263–7. PMID: 32580916. DOI: 10.1016/j.jgo.2020.06.003. http://www.ncbi.nlm.nih.gov/pubmed/32580916 +Pubmed +DOI
• Muñoz Martín AJ, Gallardo Díaz E, García Escobar I, Macías Montero R, Martínez-Marín V, Pachón Olmos V, Pérez Segura P, Quintanar Verdúguez T, Salgado Fernández M. SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019). Clin Transl Oncol. 2020 Feb;22(2):171–86. PMID: 31981080. DOI: 10.1007/s12094-019-02263-z. http://www.ncbi.nlm.nih.gov/pubmed/31981080 +Pubmed +DOI
• Otero-Estévez O, Gallardo-Gomez M, Cadena MP de la, Rodríguez-Berrocal FJ, Cubiella J, Ramirez VH, García-Nimo L, Chiara L De. Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer. Diagnostics (Basel, Switzerland). 2020 Jun;10(7) PMID: 32605302. DOI: 10.3390/diagnostics10070437. http://www.ncbi.nlm.nih.gov/pubmed/32605302 +Pubmed +DOI
• Picó MD, Castillejo A, Murcia Ó, Giner-Calabuig M, Alustiza M, Sánchez A, Moreira L, Pellise M, Castells A, Carrillo-Palau M, Ramon Y Cajal T, Gisbert-Beamud A, Llort G, Yagüe C, López-Fernández A, Alvarez-Urturi C, Cubiella J, Rivas L, Rodríguez-Alcalde D, Herraiz M, Garau C, Dolz C, Bujanda L, Cid L, Povés C, Garzon M, Salces I, Ponce M, Hernández-Villalba L, Alenda C, Balaguer F, Soto J-L, Jover R. Clinical and Pathological Characterization of Lynch-Like Syndrome. Clin Gastroenterol Hepatol. 2020 Feb;18(2):368-374.e1. PMID: 31220642. DOI: 10.1016/j.cgh.2019.06.012. https://pubmed.ncbi.nlm.nih.gov/31220642/ +Pubmed +DOI
• Picó MD, Sánchez-Heras AB, Castillejo A, Giner-Calabuig M, Alustiza M, Sánchez A, Moreira L, Pellise M, Castells A, Llort G, Yagüe C, Ramon Y Cajal T, Gisbert-Beamud A, Cubiella J, Rivas L, Herraiz M, Garau C, Salces I, Carrillo-Palau M, Bujanda L, López-Fernández A, Alvarez-Urturi C, López MJ, Alenda C, Zapater P, Lacueva FJ, Balaguer F, Soto J-L, Murcia Ó, Jover R. Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome. Cancers (Basel). 2020 Aug;12(8) PMID: 32784934. DOI: 10.3390/cancers12082225. http://www.ncbi.nlm.nih.gov/pubmed/32784934 +Pubmed +DOI
• Pin-Vieito N, Iglesias MJ, Remedios D, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrández Á, Piñol V, Rodríguez-Alcalde D, Menéndez-Rodríguez M, García-Morales N, Pérez-Mosquera C, Cubiella J. Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort. Diagnostics (Basel, Switzerland). 2020 Dec;10(12):1036. PMID: 33276621. DOI: 10.3390/diagnostics10121036. http://www.ncbi.nlm.nih.gov/pubmed/33276621 +Pubmed +DOI
• Pin-Vieito N, Iglesias MJ, Remedios D, Rodríguez-Alonso L, Rodriguez-Moranta F, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Cubiella J, On Behalf Of The Colonpredict Study Investigators. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test. World J Gastroenterol. 2020 Jan;26(1):70–85. PMID: 31933515. DOI: 10.3748/wjg.v26.i1.70. http://www.ncbi.nlm.nih.gov/pubmed/31933515 +Pubmed +DOI
• Quintero Aldana G, Salgado M, Candamio S, Méndez JC, Jorge M, Reboredo M, Vázquez Tuñas L, Romero C, Covela M, Fernández Montes A, Carmona M, Vidal Insua Y, López R, Galician Oncological Research Group (GGIO). First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. Clin Transl Oncol. 2020 Apr;22(4):495–502. PMID: 31280434. DOI: 10.1007/s12094-019-02151-6. http://www.ncbi.nlm.nih.gov/pubmed/31280434 +Pubmed +DOI
• Rivero-Sánchez L, Arnau-Collell C, Herrero J, Remedios D, Cubiella J, García-Cougil M, Alvarez V, Albéniz E, Calvo P, Gordillo J, Puig I, López-Vicente J, Huerta A, López-Cerón M, Salces I, Peñas B, Parejo S, Rodriguez de Santiago E, Herraiz M, Carretero C, Gimeno-Garcia AZ, Saperas E, Alvarez-Urturi C, Moreira R, Rodriguez de Miguel C, Ocaña T, Moreira L, Carballal S, Sánchez A, Jung G, Castells A, Llach J, Balaguer F, Pellisé M, EndoCAR group from Spanish Gastroenterology Association (AEG) and Spanish Society of Digestive Endoscopy (SEED). White-Light Endoscopy Is Adequate for Lynch Syndrome Surveillance in a Randomized and Noninferiority Study. Gastroenterology. 2020;158(4):895-904.e1. PMID: 31520613. DOI: 10.1053/j.gastro.2019.09.003. http://www.ncbi.nlm.nih.gov/pubmed/31520613 +Pubmed +DOI
• Ron DA, Vera R, Labandeira CM, Manrique MCA, Núñez MÁ, Cid NG, Mata JG, Montes AF. Maintenance treatment in metastatic colorectal cancer: in search of the best strategy. Clin Transl Oncol. 2020 Aug;22(8):1205–15. PMID: 31898053. DOI: 10.1007/s12094-019-02267-9. http://www.ncbi.nlm.nih.gov/pubmed/31898053 +Pubmed +DOI
• Rutter MD, Bretthauer M, Hassan C, Jover R, WEO Surveillance Working Group (Joaquín Cubiella). Principles for Evaluation of Surveillance After Removal of Colorectal Polyps: Recommendations From the World Endoscopy Organization. Gastroenterology. 2020;158(6):1529-1533.e4. PMID: 32240700. DOI: 10.1053/j.gastro.2019.12.052. http://www.ncbi.nlm.nih.gov/pubmed/32240700 +Pubmed +DOI
• Sánchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L, Carballal S, Rodríguez-Alonso L, Ramon Y Cajal T, Llort G, Piñol V, López-Fernández A, Salces I, Picó MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, López-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Romero C, Bastiaansen B, Gonzalez-Acosta M, Morales-Romero B, Ocaña T, Rivero-Sánchez L, Jung G, Bessa X, Cubiella J, Jover R, Rodríguez-Moranta F, Balmaña J, Brunet J, Castells A, Dekker E, Capella G, Serra-Burriel M, Moreira L, Pellise M, Balaguer F. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clin Gastroenterol Hepatol. 2020 Nov;(E-PUB) PMID: 33157315. DOI: 10.1016/j.cgh.2020.11.002. http://www.ncbi.nlm.nih.gov/pubmed/33157315 +Pubmed +DOI
• Toma C, Díaz-Gay M, Franch-Expósito S, Arnau-Collell C, Overs B, Muñoz J, Bonjoch L, Soares de Lima Y, Ocaña T, Cuatrecasas M, Castells A, Bujanda L, Balaguer F, Cubiella J, Caldés T, Fullerton JM, Castellví-Bel S. Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer. Int J cancer. 2020;146(6):1568–77. PMID: 31525256. DOI: 10.1002/ijc.32683. http://www.ncbi.nlm.nih.gov/pubmed/31525256 +Pubmed +DOI
• Vera R, Gómez ML, Ayuso JR, Figueras J, García-Alfonso P, Martínez V, Lacasta A, Ruiz-Casado A, Safont MJ, Aparicio J, Campos JM, Cámara JC, Martín-Richard M, Montagut C, Pericay C, Vieitez JM, Falcó E, Jorge M, Marín M, Salgado M, Viúdez A. Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study. Cancers (Basel). 2020 Aug;12(8) PMID: 32806731. DOI: 10.3390/cancers12082259. http://www.ncbi.nlm.nih.gov/pubmed/32806731 +Pubmed +DOI

Artículos Científicos

• Anido-Herranz U, Fernández-Núñez N, Afonso-Afonso J, Santomé-Couto L, Medina-Colmenero A, Fernández-Calvo O, Lázaro-Quintela M, Vázquez S. Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer. Clin Transl Oncol. 2019 Mar;21(3):249–58. PMID: 30051212. DOI: 10.1007/s12094-018-1928-y. http://www.ncbi.nlm.nih.gov/pubmed/30051212 +Pubmed +DOI
• Arias Ron D, Labandeira CM, Areses Manrique MC, Sampedro Domarco P, Abdulkader I, García-Mata J, Rolfo C, González-Rivas D, Fírvida JL. Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report. Front Oncol. 2019 Sep;9(September):1–8. PMID: 31552167. DOI: 10.3389/fonc.2019.00819. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743439/pdf/fonc-09-00819.pdf +Pubmed +DOI
• Cameselle-García S, Pérez JLF, Areses MC, de Castro JDF, Mosquera-Reboredo J, García-Mata J. Primary malignant melanoma of the biliary tract: A case report and literature review. World J Clin cases. 2019 Aug;7(16):2302–8. PMID: 31531323. DOI: 10.12998/wjcc.v7.i16.2302. http://www.ncbi.nlm.nih.gov/pubmed/31531323 +Pubmed +DOI
• Carmona-Bayonas A, Jimenez-Fonseca P, Garrido M, Custodio A, Hernandez R, Lacalle A, Cano JM, Aguado G, Martínez de Castro E, Alvarez Manceñido F, Macias I, Visa L, Martín Richard M, Mangas M, Sánchez Cánovas M, Longo F, Iglesias Rey L, Martínez Lago N, Martín Carnicero A, Sánchez A, Azkárate A, Limón ML, Hernández Pérez C, Ramchandani A, Pimentel P, Cerdá P, Serrano R, Gil-Negrete A, Marín M, Hurtado A, Sánchez Bayona R, Gallego J. Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer. Thromb Haemost. 2019 Nov;119(11):1849–59. PMID: 31461750. DOI: 10.1055/s-0039-1694012. http://www.ncbi.nlm.nih.gov/pubmed/31461750 +Pubmed +DOI
• Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R. Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study. J Clin Oncol. 2019;37(28):2571–80. PMID: 31390276. DOI: 10.1200/JCO.19.00980. http://www.ncbi.nlm.nih.gov/pubmed/31390276 +Pubmed +DOI
• Díaz-Gay M, Franch-Expósito S, Arnau-Collell C, Park S, Supek F, Muñoz J, Bonjoch L, Gratacós-Mulleras A, Sánchez-Rojas PA, Esteban-Jurado C, Ocaña T, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Parra G, Laurie S, Beltran S, EPICOLON Consortium, Castells A, Bujanda L, Cubiella J, Balaguer F, Castellví-Bel S. Integrated Analysis of Germline and Tumor DNA Identifies New Candidate Genes Involved in Familial Colorectal Cancer. Cancers (Basel). 2019;11(3):1–16. PMID: 30871259. DOI: 10.3390/cancers11030362. http://www.ncbi.nlm.nih.gov/pubmed/30871259 +Pubmed +DOI
• Dobarro Castro B, Remedios Espino DR, Tejido Sandoval C, Cubiella Fernández J. Therapeutic profitability of centralising the evaluation and treatment of complex polyps. Gastroenterol Hepatol. 2019 Dec;42(10):648–9. PMID: 31324466. DOI: 10.1016/j.gastrohep.2019.03.011. http://www.ncbi.nlm.nih.gov/pubmed/31324466 +Pubmed +DOI
• Fernández Montes A, López López C, Argilés Martínez G, Páez López D, López Muñoz AM, García Paredes B, Gutiérrez Abad D, Castañón López C, Jiménez Fonseca P, Gallego Plazas J, López Doldán MC, Martínez de Castro E, Sánchez Cánovas M, Tobeña Puyal M, Llorente Ayala B, Juez Martel I, López Flores M, Carmona-Bayonas A. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis. Oncologist. 2019;24(8):e687–95. PMID: 31147489. DOI: 10.1634/theoncologist.2018-0824. http://www.ncbi.nlm.nih.gov/pubmed/31147489 +Pubmed +DOI
• Fernández Montes A, Martínez Lago N, Covela Rúa M, de la Cámara Gómez J, González Villaroel P, Méndez Méndez JC, Jorge Fernández M, Salgado Fernández M, Reboredo López M, Quintero Aldana G, Luz Pellón Augusto M, Graña Suárez B, García Gómez J. Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers. Cancer Med. 2019 Mar;8(3):882–9. PMID: 30690930. DOI: 10.1002/cam4.1903. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434192/pdf/CAM4-8-882.pdf +Pubmed +DOI
• Fernández-de Castro JD, Baiocchi Ureta F, Fernández González R, Pin Vieito N, Cubiella Fernández J. The effect of diagnostic delay attributable to the healthcare system on the prognosis of colorectal cancer. Gastroenterol Hepatol. 2019 Nov;42(9):527–33. PMID: 31421857. DOI: 10.1016/j.gastrohep.2019.03.012. http://www.ncbi.nlm.nih.gov/pubmed/31421857 +Pubmed +DOI
• Font A, Luque R, Villa JC, Domenech M, Vázquez S, Gallardo E, Virizuela JA, Beato C, Morales-Barrera R, Gelabert A, Maciá S, Puente J, Rubio G, Maldonado X, Perez-Valderrama B, Pinto A, Fernández Calvo O, Grande E, Garde-Noguera J, Fernández-Parra E, Arranz JÁ. The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG). Target Oncol. 2019;14(1):15–32. PMID: 30694442. DOI: 10.1007/s11523-019-00619-7. http://www.ncbi.nlm.nih.gov/pubmed/30694442 +Pubmed +DOI
• Herreros-Villanueva M, Duran-Sanchon S, Martín AC, Pérez-Palacios R, Vila-Navarro E, Marcuello M, Diaz-Centeno M, Cubiella J, Diez MS, Bujanda L, Lanas A, Jover R, Hernández V, Quintero E, José Lozano J, García-Cougil M, Martínez-Arranz I, Castells A, Gironella M, Arroyo R. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Clin Transl Gastroenterol. 2019;10(1):e00003. PMID: 30702491. DOI: 10.14309/ctg.0000000000000003. https://www.ncbi.nlm.nih.gov/30702491 +Pubmed +DOI
• Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers. Aliment Pharmacol Ther. 2019;49(11):1410–20. PMID: 31025420. DOI: 10.1111/apt.15251. http://www.ncbi.nlm.nih.gov/pubmed/31025420 +Pubmed +DOI
• Mangas-Sanjuan C, Jover R, Cubiella J, Marzo-Castillejo M, Balaguer F, Bessa X, Bujanda L, Bustamante M, Castells A, Diaz-Tasende J, Díez-Redondo P, Herráiz M, Mascort-Roca JJ, Pellisé M, Quintero E, Grupo de Cribado del Cáncer Colorrectal de la Sociedad Española de Epidemiología. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update. Gastroenterol Hepatol. 2019 Mar;42(3):188–201. PMID: 30621911. DOI: 10.1016/j.gastrohep.2018.11.001. http://www.ncbi.nlm.nih.gov/pubmed/30621911 +Pubmed +DOI
• Marín Barrera L, Muñoz Martín A, Ríos Herranz E, García-Escobar I, Beato C, Font C, Oncala Sibajas E, Revuelta Rodríguez A, Areses-Manrique MC, Rivas Jiménez V, Moreno Santos M, Ballaz Quincoces A, Gallego Gallego I, Elías Hernández T, Asensio Cruz M, García González G, Otero Candelera L. Calidad de vida relacionada con la salud en pacientes oncológicos con enfermedad tromboembólica venosa aguda sintomática. Diseño del estudio QCA (Quality of Life in Cancer). Rev española Patol torácica. 2019;31(4):249–58. https://www.rev-esp-patol-torac.com/resumen_articulo.php?id=279&idarticulo=1628&y=2019 Enlace
• Marin-Barrera L, Muñoz-Martin AJ, Rios-Herranz E, Garcia-Escobar I, Beato C, Font C, Oncala-Sibajas E, Revuelta-Rodriguez A, Areses MC, Rivas-Jimenez V, Moreno-Santos MA, Ballaz-Quincoces A, Lopez-Saez J-B, Gallego I, Elias-Hernandez T, Asensio-Cruz MI, Chasco-Eguilaz L, Garcia-Gonzalez G, Estevez-Garcia P, Otero R, Lima-Alvarez J, Jara-Palomares L. A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study. Cancers (Basel). 2019 Dec;12(1) PMID: 31888065. DOI: 10.3390/cancers12010075. http://www.ncbi.nlm.nih.gov/pubmed/31888065 +Pubmed +DOI
• Ortega-Granados AL, Artal-Cortes Á, Aguiar-Bujanda D, Oramas J, Fírvida JL, DE Castro J, Fuentes JC, Gordo R, Galán R, Trigo J, ASPET Study Investigators. Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer. Anticancer Res. 2019 Mar;39(3):1317–28. PMID: 30842164. DOI: 10.21873/anticanres.13244. http://www.ncbi.nlm.nih.gov/pubmed/30842164 +Pubmed +DOI
• Pin Vieito N, Zarraquiños S, Cubiella J. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis. World J Gastroenterol. 2019 May;25(19):2383–401. PMID: 31148909. DOI: 10.3748/wjg.v25.i19.2383. http://www.ncbi.nlm.nih.gov/pubmed/31148909 +Pubmed +DOI
• Puga M, Pallarès N, Velásquez-Rodríguez J, García-Sumalla A, Consiglieri CF, Busquets J, Laquente B, Calvo M, Fabregat J, Castellote J, Gornals JB. Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study. Rev Esp Enferm Dig. 2019 Sep;111(9):683–9. PMID: 31333037. DOI: 10.17235/reed.2019.6225/2019. http://www.ncbi.nlm.nih.gov/pubmed/31333037 +Pubmed +DOI
• Puig I, López-Cerón M, Arnau A, Rosiñol Ò, Cuatrecasas M, Herreros-de-Tejada A, Ferrández Á, Serra-Burriel M, Nogales Ó, Vida F, de Castro L, López-Vicente J, Vega P, Álvarez-González MA, González-Santiago J, Hernández-Conde M, Díez-Redondo P, Rivero-Sánchez L, Gimeno-García AZ, Burgos A, García-Alonso FJ, Bustamante-Balén M, Martínez-Bauer E, Peñas B, Pellise M, EndoCAR group SGA and the SDES (V HJC. Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps. Gastroenterology. 2019 Oct;156(1):75–87. PMID: 30296432. DOI: 10.1053/j.gastro.2018.10.004. http://www.ncbi.nlm.nih.gov/pubmed/30296432 +Pubmed +DOI
• Rodríguez-Alcalde D, Carballal S, Moreira L, Hernández L, Rodríguez-Alonso L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, Saperas E, López-Cerón M, Cuatrecasas M, López-Vicente J, Rivero-Sánchez L, Jung G, Vila-Casadesús M, Sánchez A, Castells A, Pellisé M, Balaguer F, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome. Endoscopy. 2019 Aug;51(2):142–51. PMID: 30068004. DOI: 10.1055/a-0656-5557. http://www.ncbi.nlm.nih.gov/pubmed/30068004 +Pubmed +DOI
• Ruiz-Bañobre J, Areses-Manrique MC, Mosquera-Martínez J, Cortegoso A, Afonso-Afonso FJ, de Dios-Álvarez N, Fernández-Núñez N, Azpitarte-Raposeiras C, Amenedo M, Santomé L, Fírvida-Pérez JL, García-Campelo R, García-González J, Casal-Rubio J, Vázquez S. Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy. Transl lung cancer Res. 2019 Dec;8(6):1078–85. PMID: 32010585. DOI: 10.21037/tlcr.2019.11.07. http://www.ncbi.nlm.nih.gov/pubmed/32010585 +Pubmed +DOI
• Sánchez-Rovira P, Zamora P, Salvador-Bofill J, Morales S, Martínez-Jáñez N, Martínez-de-Dueñas E, Lluch A, Illarramendi JJ, Gómez-Pardo P, Gavilá Gregori J, García-Palomo A, García-Mata J, Fernández Y, Del Barco S, de Juan A, Ciruelos E, Chacón JI, Calvo L, Barnadas A, Albanell J. Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists. J drug Assess. 2019;8(1):62–9. PMID: 31069129. DOI: 10.1080/21556660.2019.1604375. http://www.ncbi.nlm.nih.gov/pubmed/31069129 +Pubmed +DOI
• Toma C, Díaz-Gay M, Soares de Lima Y, Arnau-Collell C, Franch-Expósito S, Muñoz J, Overs B, Bonjoch L, Carballal S, Ocaña T, Cuatrecasas M, Díaz de Bustamante A, Castells A, Bujanda L, Cubiella J, Balaguer F, Rodríguez-Alcalde D, Fullerton JM, Castellví-Bel S. Identification of a Novel Candidate Gene for Serrated Polyposis Syndrome Germline Predisposition by Performing Linkage Analysis Combined With Whole-Exome Sequencing. Clin Transl Gastroenterol. 2019;10(10):e00100. PMID: 31663907. DOI: 10.14309/ctg.0000000000000100. http://www.ncbi.nlm.nih.gov/pubmed/31663907 +Pubmed +DOI

Guías de Práctica Clínica

• Campos Balea B, Fernández Bouza E, Barbagelata López C, Brozos Vázquez EM, CAROU FRIEIRO, IRIA; Fernández Pérez I, Iglesias Rey L, Quindós Varela M, Carmona Campos M, Antolín Novoa S. Guía gallega de manejo de la trombosis asociada a cáncer. Rivera Gallego A, Lopez-Lopez R (eds.). Barcelona: Bubblegum Communication Services; 2019. Con el Aval de la Sociedad Oncológica de Galicia (. ISBN: 978-84-09-1419-4. https://runa.sergas.es/xmlui/handle/20.500.11940/12881 Enlace
• Lamelo-Alfonsín F, Fernández-Calvo O, Charlín-Pato G. Guías clínicas Fisterra: Control de síntomas en cuidados paliativos. 2019. https://www.fisterra.com/guias-clinicas/control-sintomas-cuidados-paliativos/ Enlace

Artículos Científicos

• Albéniz E, Pellisé M, Gimeno García AZ, Lucendo AJ, Alonso Aguirre PA, Herreros de Tejada A, Álvarez MA, Fraile M, Herráiz Bayod M, López Rosés L, Martínez Ares D, Ono A, Parra Blanco A, Redondo E, Sánchez Yagüe A, Soto S, Díaz Tasende J, Montes Díaz M, Téllez MR, García O, Zuñiga Ripa A, Hernández Conde M, Alberca de Las Parras F, Gargallo C, Saperas E, Navas MM, Gordillo J, Ramos Zabala F, Echevarría JM, Bustamante M, González Haba M, González Huix F, González Suárez B, Vila Costas JJ, Guarner Argente C, Múgica F, Cobián J, Rodríguez Sánchez J, López Viedma B, Pin N, Marín Gabriel JC, Nogales Ó, de la Peña J, Navajas León FJ, León Brito H, Remedios D, Esteban JM, Barquero D, Martínez Cara JG, Martínez Alcalá F, Fernández Urién I, Valdivielso E, en nombre del Grupo Español de Resección Endoscópica de la Sociedad Española de Endoscopia Digestiva. Clinical guidelines for endoscopic mucosal resection of non-pedunculated colorectal lesions. Gastroenterol Hepatol. 2018 Mar;41(3):175–90. PMID: 29449039. DOI: 10.1 +Pubmed +DOI
• Areses Manrique MC, Mosquera Martínez J, García González J, Afonso Afonso FJ, Lázaro Quintela M, Fernández Núñez N, Azpitarte Raposeiras C, Amenedo Gancedo M, Santomé Couto L, García Campelo MR, Muñoz Iglesias J, Cortegoso Mosquera A, Vilchez Simo R, Casal Rubio J, Campos Balea B, Carou Frieiro I, Alonso-Jaudenes Curbera G, Anido Herranz U, García Mata J, Fírvida Pérez JL. Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience. Transl lung cancer Res. 2018 Jun;7(3):404–15. PMID: 30050778. DOI: 10.21037/tlcr.2018.04.03. http://www.ncbi.nlm.nih.gov/pubmed/30050778 +Pubmed +DOI
• Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, Guardiola J, Cañas M, Gobbo Montoya M, Modino Y, Alcaín G, Bosca-Watts MM, Calvet X, Casellas F, Chaparro M, Fernández Salazar L, Ferreiro-Iglesias R, Ginard D, Iborra M, Manceñido N, Mañosa M, Merino O, Rivero M, Roncero O, Sempere L, Vega P, Zabana Y, Mínguez M, Nos P, Gisbert JP. Recommendations of the Spanish Working Group on Crohn´s Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn´s Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patien. Gastroenterol Hepatol. 2018 Feb;41(2):118–27. PMID: 29275001. DOI: 10.1016/j.gastrohep.2017.10.003. http://www.ncbi.nlm.nih.gov/pubmed/29275001 +Pubmed +DOI
• Bujanda L, Sarasqueta C, Vega P, Salve M, Quintero E, Alvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Garayoa A, Ferrandez A, Torrealba L, Rodríguez-Alcaide D, D´Amato M, Hernández V, Cubiella J. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia. United Eur Gastroenterol J. 2018 Feb;6(1):123–30. PMID: 29435322. DOI: 10.1177/2050640617707094. http://www.ncbi.nlm.nih.gov/pubmed/29435322 +Pubmed +DOI
• Carballal S, Maisterra S, López-Serrano A, Gimeno-García AZ, Vera MI, Marín-Garbriel JC, Díaz-Tasende J, Márquez L, Álvarez MA, Hernández L, De Castro L, Gordillo J, Puig I, Vega P, Bustamante-Balén M, Acevedo J, Peñas B, López-Cerón M, Ricart E, Cuatrecasas M, Jimeno M, Pellisé M, EndoCAR group of the Spanish Gastroenterological Association and Spanish Digestive Endoscopy Society. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut. 2018 Jan;67(1):70–8. PMID: 27612488. DOI: 10.1136/gutjnl-2016-312332. http://www.ncbi.nlm.nih.gov/pubmed/27612488 +Pubmed +DOI
• Carot L, Castells A, Hernández C, Alvarez-Urturi C, Balaguer F, Lanas A, Cubiella J, Tasende JD, Jover R, Hernandez V, Carballo F, Bujanda L, Quintero E, Andreu M, Bessa X. Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial. United Eur Gastroenterol J. 2018 Dec;6(10):1527–37. PMID: 30574323. DOI: 10.1177/2050640618804722. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297927/pdf/10.1177_2050640618804722.pdf +Pubmed +DOI
• Costa Rivas M, Huidobro Vence G, Fírvida Pérez JL, Campos Balea B, García Gonzalez J, Lázaro Quintela M, Caeiro Muñoz M, Taboada Valladares B, Castro Gómez JE, Vázquez Estevez S, Afonso Afonso FJ, Azpitarte Raposeiras C, Amenedo Gancedo M, Casal Rubio J. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group. Clin Transl Oncol. 2018 Nov;20(11):1467–73. PMID: 29696478. DOI: 10.1007/s12094-018-1880-x. http://www.ncbi.nlm.nih.gov/pubmed/29696478 +Pubmed +DOI
• Cubiella J, Clos-Garcia M, Alonso C, Martinez-Arranz I, Perez-Cormenzana M, Barrenetxea Z, Berganza J, Rodríguez-Llopis I, D´Amato M, Bujanda L, Diaz-Ondina M, Falcón-Pérez JM. Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer. Cancers (Basel). 2018 Sep;10(9):300. PMID: 30200467. DOI: 10.3390/cancers10090300. http://www.ncbi.nlm.nih.gov/pubmed/30200467 +Pubmed +DOI
• Cubiella J, Marzo-Castillejo M, Mascort-Roca JJ, Amador-Romero FJ, Bellas-Beceiro B, Clofent-Vilaplana J, Carballal S, Ferrándiz-Santos J, Gimeno-García AZ, Jover R, Mangas-Sanjuán C, Moreira L, Pellisè M, Quintero E, Rodríguez-Camacho E, Vega-Villaamil P, Sociedad Española de Medicina de Familia y Comunitaria y Asociación Española de Gastroenterología. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update. Gastroenterol Hepatol. 2018 Nov;41(9):585–96. PMID: 30245076. DOI: 10.1016/j.gastrohep.2018.07.012. http://www.ncbi.nlm.nih.gov/pubmed/30245076 +Pubmed +DOI
• Esteban I, Vilaró M, Adrover E, Angulo A, Carrasco E, Gadea N, Sánchez A, Ocaña T, Llort G, Jover R, Cubiella J, Servitja S, Herráiz M, Cid L, Martínez S, Oruezábal-Moreno MJ, Garau I, Khorrami S, Herreros-de-Tejada A, Morales R, Cano JM, Serrano R, López-Ceballos MH, González-Santiago S, Juan-Fita MJ, Alonso-Cerezo C, Casas A, Graña B, Teulé A, Alba E, Antón A, Guillén-Ponce C, Sánchez-Heras AB, Alés-Martínez JE, Brunet J, Balaguer F, Balmaña J. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology. 2018 Jun;27(6):1530–7. PMID: 29498768. DOI: 10.1002/pon.4686. http://www.ncbi.nlm.nih.gov/pubmed/29498768 +Pubmed +DOI
• Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study. BMC Cancer. BMC Cancer; 2018 Nov;18(1):1185. PMID: 30497432. DOI: 10.1186/s12885-018-5101-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267080/pdf/12885_2018_Article_5101.pdf +Pubmed +DOI
• Gallardo-Gómez M, Moran S, Páez de la Cadena M, Martínez-Zorzano VS, Rodríguez-Berrocal FJ, Rodríguez-Girondo M, Esteller M, Cubiella J, Bujanda L, Castells A, Balaguer F, Jover R, De Chiara L. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Clin Epigenetics. Clinical Epigenetics; 2018 Dec;10(1):53. PMID: 29686738. DOI: 10.1186/s13148-018-0487-y. http://www.ncbi.nlm.nih.gov/pubmed/29686738 +Pubmed +DOI
• Gándara-Cortes M, Vázquez-Boquete Á, Fernández-Rodríguez B, Viaño P, Ínsua D, Seoane-Seoane A, Gude F, Gallego R, Fraga M, Antúnez JR, Curiel T, Pérez-López E, García-Caballero T. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis. Virchows Arch. 2018 Feb;472(2):195–203. PMID: 28825136. DOI: 10.1007/s00428-017-2194-z. IF2016: 2.848; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28825136 +Pubmed +DOI
• García-Alfonso P, Benavides M, Falcó E, Muñoz A, Gómez A, Sastre J, Rivera F, Montagut C, Salgado M, López-Ladrón A, López R, Ruiz de Mena I, Durán G, Aranda E, Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial). Oncologist. 2018 Aug;23(11):1271-e128. PMID: 30120161. DOI: 10.1634/theoncologist.2018-0316. http://www.ncbi.nlm.nih.gov/pubmed/30120161 +Pubmed +DOI
• García-Mata J, Álamo C, de Castro J, Contreras J, Gálvez R, Jara C, Llombart A, Pérez C, Sánchez P, Traseira S, Cruz J-J. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain. Clin Transl Oncol. 2018 Aug;20(8):1061–71. PMID: 29721765. DOI: 10.1007/s12094-017-1826-8. http://www.ncbi.nlm.nih.gov/pubmed/29721765 +Pubmed +DOI
• Herrero J-M, Vega P, Salve M, Bujanda L, Cubiella J. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study. BMC Gastroenterol. 2018 Oct;18(1):155. PMID: 30359225. DOI: 10.1186/s12876-018-0887-7. http://www.ncbi.nlm.nih.gov/pubmed/30359225 +Pubmed +DOI
• López-Vicente J, Rodríguez-Alcalde D, Hernández L, Riu Pons F, Vega P, Herrero Rivas JM, Santiago García J, Salces Franco I, Bustamante Balén M, López-Cerón M, Pellisé M, Endoscopy for High Risk Cancer Conditions group of the Spanish Gastroenterological Association and Spanish Digestive Endoscopy Society. Panchromoendoscopy Increases Detection of Polyps in Patients With Serrated Polyposis Syndrome. Clin Gastroenterol Hepatol. 2018 Sep;17(10):2016-2023.e6. PMID: 30366156. DOI: 10.1016/j.cgh.2018.10.029. http://www.ncbi.nlm.nih.gov/pubmed/30366156 +Pubmed +DOI
• Mangas-Sanjuan C, Zapater P, Cubiella J, Murcia Ó, Bujanda L, Hernández V, Martínez-Ares D, Pellisé M, Seoane A, Lanas Á, Nicolás-Pérez D, Herreros-de-Tejada A, Chaparro M, Cacho G, Fernández-Díez S, Marín-Gabriel J-C, Quintero E, Castells A, Jover R, COLONPREV study investigators (Susana Aldecoa; Carlos Menéndez). Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox. United Eur Gastroenterol J. 2018 May;6(4):622–9. PMID: 29881618. DOI: 10.1177/2050640617745458. http://www.ncbi.nlm.nih.gov/pubmed/29881618 +Pubmed +DOI
• Maximiano C, López I, Martín C, Zugazabeitia L, Martí-Ciriquián JL, Núñez MA, Contreras J, Herdman M, Traseira S, Provencio M. An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement. PLoS One. 2018;13(4):e0193233. PMID: 29614068. DOI: 10.1371/journal.pone.0193233. http://www.ncbi.nlm.nih.gov/pubmed/29614068 +Pubmed +DOI
• Munoz Martin AJ, Ortega I, Font C, Pachon V, Castellon V, Martinez-Marin V, Salgado M, Martinez E, Calzas J, Ruperez A, Souto JC, Martin M, Salas E, Soria JM. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. Br J Cancer. Springer US; 2018 Apr;118(8):1056–61. PMID: 29588512. DOI: 10.1038/s41416-018-0027-8. http://www.ncbi.nlm.nih.gov/pubmed/29588512 +Pubmed +DOI
• Sabell Pérez-Salgado F, Vázquez-Estévez S, Anido-Herranz U, Blanco-Parra M, Casas-Nebra FJ, Fernández-Calvo O, Lázaro-Quintela M, López-García S. Approach of the patient with renal cancer: Is there a collaboration between urology and oncology? Actas Urol Esp. 2018 Jan;42(1):1–4. PMID: 28587846. DOI: 10.1016/j.acuro.2017.04.001. http://www.ncbi.nlm.nih.gov/pubmed/28587846 +Pubmed +DOI
• Visa L, Jiménez-Fonseca P, Asensio-Martínez E, Hernández R, Custodio A, Garrido M, Viudez A, Buxo E, Echavarria I, Cano JM, Macias I, Mangas M, Martínez-de Castro E, García T, Álvarez-Manceñido F, Fernández-Montes A, Azkarate A, Longo F, Díaz-Serrano A, López C, Hurtado A, Cerdá P, Serrano R, Gil-Negrete A, Martín-Carnicero A, Pimentel P, Ramchandani A, Carmona-Bayonas A. Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis. J Geriatr Oncol. 2018 May;9(3):254–64. PMID: 29242093. DOI: 10.1016/j.jgo.2017.11.008. http://www.ncbi.nlm.nih.gov/pubmed/29242093 +Pubmed +DOI

Guías de Práctica Clínica

• Grupo de Trabajo Responsable de la Actualización de la GPC de Diagnóstico y Prevención del Cáncer Colorrectal (Joaquín Cubiella; Pablo Vega). Diagnóstico y prevención del cáncer colorrectal. Actualización 2018. Cubiella-Fernández J, Marzo-Castillejo M, Mascort-Roca JJ (eds.). Asociación Española de Gastroenterología y Sociedad Española de Medicina de Familia y Comunitaria; IMC; 2018. DL: M-29238-2018. ISBN: 978-84-7867-620-0. https://www.aegastro.es/sites/default/files/archivos/guia-clinica/actualizacion_prevencion_cancer_colorrectal.pdf Enlace

Artículos Científicos

• Climent MÁ, Pérez-Valderrama B, Mellado B, Fernández Parra EM, Fernández Calvo O, Ochoa de Olza M, Muinelo Romay L, Anido U, Domenech M, Hernando Polo S, Arranz Arija JÁ, Caballero C, Juan Fita MJ, Castellano D. Weekly cabazitaxel plus prednisone is effective and less toxic for ´unfit´ metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial. Eur J Cancer. 2017 Dec;87:30–7. PMID: 29102858. DOI: 10.1016/j.ejca.2017.09.028. IF2017: 7.191; Q1. http://www.ncbi.nlm.nih.gov/pubmed/29102858 +Pubmed +DOI
• Cubiella J, Castells A, Andreu M, Bujanda L, Carballo F, Jover R, Lanas Á, Morillas JD, Salas D, Quintero E, COLONPREV study investigators (Susana Aldecoa; Inés Castro; Vicent Hernández; Carlos Menéndez). Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs. United Eur Gastroenterol J. 2017 Mar;5(2):255–60. PMID: 28344793. DOI: 10.1177/2050640616660662. IF2017: 3.477; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28344793 +Pubmed +DOI
• Cubiella J, Digby J, Rodríguez-Alonso L, Vega P, Salve M, Díaz-Ondina M, Strachan JA, Mowat C, McDonald PJ, Carey FA, Godber IM, Younes H Ben, Rodriguez-Moranta F, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Garayoa A, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Steele RJC, Fraser CG, COLONPREDICT study investigators. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients. Int J cancer. 2017 May;140(10):2201–11. PMID: 28187494. DOI: 10.1002/ijc.30639. IF2017: 7.360; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28187494 +Pubmed +DOI
• Cueva JF, Antolín S, Calvo L, Fernández I, Ramos M, de Paz L, Mata JG, López R, Constenla M, Pérez E, González A, Pellón ML, Varela S, López T. Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention. Clin Transl Oncol. 2017 Sep;19(9):1067–78. PMID: 28342058. DOI: 10.1007/s12094-017-1648-8. IF2017: 2.392; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28342058 +Pubmed +DOI
• Custodio A, Carmona-Bayonas A, Jiménez-Fonseca P, Sánchez ML, Viudez A, Hernández R, Cano JM, Echavarria I, Pericay C, Mangas M, Visa L, Buxo E, García T, Rodríguez Palomo A, Álvarez Manceñido F, Lacalle A, Macias I, Azkarate A, Ramchandani A, Fernández-Montes A, López C, Longo F, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Hurtado A, Madero R, Gómez C, Gallego J. Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab. Br J Cancer. 2017 Jun;116(12):1526–35. PMID: 28463962. DOI: 10.1038/bjc.2017.122. IF2017: 5.922; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28463962 +Pubmed +DOI
• Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, De-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel J-C, Balmaña J, Piñol V, Rodríguez Moranta F, Nicolás-Pérez D, Cuatrecasas M, Balaguer F, Castells A, Soto J-L, Zapater P, Jover R. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives. Gastroenterology. 2017 Jul;153(1):106-112.e2. PMID: 28400194. DOI: 10.1053/j.gastro.2017.04.003. IF2017: 20.773; D1. http://www.ncbi.nlm.nih.gov/pubmed/28400194 +Pubmed +DOI
• Esteban-Jurado C, Giménez-Zaragoza D, Muñoz J, Franch-Expósito S, Álvarez-Barona M, Ocaña T, Cuatrecasas M, Carballal S, López-Cerón M, Marti-Solano M, Díaz-Gay M, van Wezel T, Castells A, Bujanda L, Balmaña J, Gonzalo V, Llort G, Ruiz-Ponte C, Cubiella J, Balaguer F, Aligué R, Castellví-Bel S. POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer. Oncotarget. 2017 Apr;8(16):26732–43. PMID: 28423643. DOI: 10.18632/oncotarget.15810. IF2017: 5.168; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28423643 +Pubmed +DOI
• Marzo-Castillejo M, Cubiella-Fernández J, Mascort-Roca J, Pastor Rodriguez-Moñino A. [Primary care and detection of colorectal cancer]. Aten primaria. 2017 Dec;49(10):565–7. PMID: 29195689. DOI: 10.1016/j.aprim.2017.11.001. IF2017: 1.148; Q3. http://www.ncbi.nlm.nih.gov/pubmed/29195689 +Pubmed +DOI
• Menéndez Villalva C, López Alvarez-Muiño XL, Gamarra Mondelo T, Alonso Fachado A, Cubiella Fernández J. Adherence to Treatment in Hypertension. Adv Exp Med Biol. 2017 Oct;956:129–47. PMID: 27757938. DOI: 10.1007/5584_2016_77. IF2017: 1.760; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27757938 +Pubmed +DOI
• Mestres JA, IMolins AB, Martínez LC, López-Muñiz JIC, Gil EC, de Juan Ferré A, Del Barco Berrón S, Pérez YF, Mata JG, Palomo AG, Gregori JG, Pardo PG, Mañas JJI, Hernández AL, de Dueñas EM, Jáñez NM, Murillo SM, Bofill JS, Auñón PZ, Sanchez-Rovira P. Defining the optimal sequence for the systemic treatment of metastatic breast cancer. Clin Transl Oncol. 2017 Feb;19(2):149–61. PMID: 27314861. DOI: 10.1007/s12094-016-1520-2. IF2017: 2.392; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27314861 +Pubmed +DOI
• Westwood M, Lang S, Armstrong N, van Turenhout S, Cubiella J, Stirk L, Ramos IC, Luyendijk M, Zaim R, Kleijnen J, Fraser CG. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Med. 2017 Dec;15(1):189. PMID: 29061126. DOI: 10.1186/s12916-017-0944-z. IF2017: 9.088; D1. http://www.ncbi.nlm.nih.gov/pubmed/29061126 +Pubmed +DOI

Artículos Científicos

• Albéniz E, Fraile M, Ibáñez B, Alonso-Aguirre P, Martínez-Ares D, Soto S, Gargallo CJ, Ramos Zabala F, Álvarez MA, Rodríguez-Sánchez J, Múgica F, Nogales Ó, Herreros de Tejada A, Redondo E, Guarner-Argente C, Pin N, León-Brito H, Pardeiro R, López-Roses L, Rodríguez-Téllez M, Jiménez A, Martínez-Alcalá F, García O, de la Peña J, Ono A, Alberca de Las Parras F, Pellisé M, Rivero L, Saperas E, Pérez-Roldán F, Pueyo Royo A, Eguaras Ros J, Zúñiga Ripa A, Concepción-Martín M, Huelin-Álvarez P, Colán-Hernández J, Cubiella J, Remedios D, Bessa I Caserras X, López-Viedma B, Cobian J, González-Haba M, Santiago J, Martínez-Cara JG, Valdivielso E, Endoscopic Mucosal Resection Endoscopic Spanish Society Group. A Scoring System to Determine Risk of Delayed Bleeding After Endoscopic Mucosal Resection of Large Colorectal Lesions. Clin Gastroenterol Hepatol. 2016 Aug;14(8):1140–7. PMID: 27033428. DOI: 10.1016/j.cgh.2016.03.021. IF2016: 7.398; D1. http://www.ncbi.nlm.nih.gov/pubmed/27033428 +Pubmed +DOI
• Alvarez-Urturi C, Andreu M, Hernandez C, Perez-Riquelme F, Carballo F, Ono A, Cruzado J, Cubiella JJ, Hernandez V, Mao CG, Perez E, Salas D, Andres M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Auge JM, Castells A, Bessa X, Andrés M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Augé JM, Castells A, Bessa X, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening. Dig Liver Dis. 2016 May;48(5):542–51. PMID: 26936343. DOI: 10.1016/j.dld.2016.02.001. IF2016: 3.061; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26936343 +Pubmed +DOI
• Areses Manrique MC, Iglesias Rey L, Cubiella J. The long road from molecular biology to clinical practice in colorectal cancer. Gastroenterol Hepatol. 2016 Aug;39(7):429–32. PMID: 26847767. DOI: 10.1016/j.gastrohep.2015.11.005. IF2016: 0.917; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26847767 +Pubmed +DOI
• Baldaque-Silva F, Marques M, Sanchez-Hernandez E, Santos-Antunes J, Coelho R, Vilas-Boas F, Lopes J, Carneiro F, Macedo G. Endoscopic Submucosal Dissection of a Giant Esophageal Lipoma. Am J Gastroenterol. 2016 Dec;111(12):1680. PMID: 27924084. DOI: 10.1038/ajg.2016.272. IF2016: 9.566; D1. http://www.ncbi.nlm.nih.gov/pubmed/27924084 +Pubmed +DOI
• Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, López-Cerón M, Cuatrecasas M, López-Vicente J, Leoz ML, Rivero-Sánchez L, Castells A, Pellisé M, Balaguer F, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2016 Nov;65(11):1829–37. PMID: 26264224. DOI: 10.1136/gutjnl-2015-309647. IF2016: 16.658; D1. http://www.ncbi.nlm.nih.gov/pubmed/26264224 +Pubmed +DOI
• Carmona-Bayonas A, Jiménez-Fonseca P, Lorenzo MLS, Ramchandani A, Martínez EA, Custodio A, Garrido M, Echavarría I, Cano JM, Barreto JEL, García TG, Manceñido FÁ, Lacalle A, Cardona MF, Mangas M, Visa L, Buxó E, Azkarate A, Díaz-Serrano A, Montes AF, Rivera F. On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry. J Natl Compr Canc Netw. 2016 Nov;14(11):1379–88. PMID: 27799509. IF2016: 4.675; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27799509 +Pubmed
• Cubiella J, Carballo F, Portillo I, Cruzado Quevedo J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A. Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines. Endoscopy. 2016 Nov;48(11):995–1002. PMID: 27485482. DOI: 10.1055/s-0042-112571. IF2016: 5.444; D1. http://www.ncbi.nlm.nih.gov/pubmed/27485482 +Pubmed +DOI
• Cubiella J, Vega P, Salve M, Díaz-Ondina M, Alves MT, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Clofent J, Ferrandez Á, Torrealba L, Piñol V, Rodríguez-Alcalde D, Hernández V, Fernández-Seara J, COLONPREDICT study investigators. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients. BMC Med. 2016 Aug;14(1):128. PMID: 27580745. DOI: 10.1186/s12916-016-0668-5. IF2016: 7.901; D1. http://www.ncbi.nlm.nih.gov/pubmed/27580745 +Pubmed +DOI
• Esteban-Jurado C, Franch-Expósito S, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Serra E, Beltran S, Brea-Fernández A, Ruiz-Ponte C, Castells A, Bujanda L, Garre P, Caldés T, Cubiella J, Balaguer F, Castellví-Bel S. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. Eur J Hum Genet. 2016 Oct;24(10):1501–5. PMID: 27165003. DOI: 10.1038/ejhg.2016.44. IF2016: 4.287; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27165003 +Pubmed +DOI
• García J, Santomé L, Anido U, Fernández-Calvo O, Afonso-Afonso J, Lázaro M, Medina A, Vázquez Estévez S. Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU). Curr Oncol Rep. 2016 Dec;18(12):72. PMID: 27812861. DOI: 10.1007/s11912-016-0556-3. IF2016: 2.608; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27812861 +Pubmed +DOI
• Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E, COLONPREV Study Investigators (Susana Aldecoa; Inés Castro). Endoscopist characteristics that influence the quality of colonoscopy. Endoscopy. 2016 Mar;48(3):241–7. PMID: 26845473. DOI: 10.1055/s-0042-100185. IF2016: 5.444; D1. http://www.ncbi.nlm.nih.gov/pubmed/26845473 +Pubmed +DOI
• Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM, Thibodeau SN, Newcomb P, Win AK, Jenkins M, Buchanan DD, Bertario L, Sala P, Hampel H, Syngal S, Steyerberg EW, Lynch Syndrome prediction model validation study group (J Cubiella; V Hernández). Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. J Natl Cancer Inst. 2016 Feb;108(2):1-9 (djv308). PMID: 26582061. DOI: 10.1093/jnci/djv308. IF2016: 12.589; D1. http://www.ncbi.nlm.nih.gov/pubmed/26582061 +Pubmed +DOI
• Lainez N, García-Donas J, Esteban E, Puente J, Sáez MI, Gallardo E, Pinto-Marín Á, Vázquez-Estévez S, León L, García-Carbonero I, Suárez-Rodríguez C, Molins C, Climent-Duran MA, Lázaro-Quintela M, González Del Alba A, Méndez-Vidal MJ, Chirivella I, Afonso FJ, López-Brea M, Sala-González N, Domenech M, Basterretxea L, Santander-Lobera C, Gil-Arnáiz I, Fernández O, Caballero-Díaz C, Mellado B, Marrupe D, García-Sánchez J, Sánchez-Escribano R, Fernández Parra E, Villa Guzmán JC, Martínez-Ortega E, Belén González M, Morán M, Suarez-Paniagua B, Lecumberri MJ, Castellano D. Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study. BMC Cancer. 2016 Feb;16(1):135. PMID: 26906039. DOI: 10.1186/s12885-016-2084-9. IF2016: 3.288; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26906039 +Pubmed +DOI
• Otero-Estévez O, De Chiara L, Barcia-Castro L, Páez de la Cadena M, Rodríguez-Berrocal FJ, Cubiella J, Hernández V, Martínez-Zorzano VS. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer. Sci Rep. Nature Publishing Group; 2016 May;6(November 2015):26703. PMID: 27222072. DOI: 10.1038/srep26703. IF2016: 4.259; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27222072 +Pubmed +DOI
• Pérez-López ME, García-Gómez J, Alves MT, Paradela A, García-Mata J, García-Caballero T. Ki-67 is a prognostic marker for hormone receptor positive tumors. Clin Transl Oncol. 2016 Oct;18(10):996–1002. PMID: 26742937. DOI: 10.1007/s12094-015-1472-y. IF2016: 2.353; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26742937 +Pubmed +DOI
• Quintero E, Carrillo M, Leoz M-L, Cubiella J, Gargallo C, Lanas A, Bujanda L, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Morillas JD, Balaguer F, Muriel A, Oncology Group of the Asociación Española de Gastroenterología (AEG). Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLoS Med. 2016 May;13(5):e1002008. PMID: 27138769. DOI: 10.1371/journal.pmed.1002008. IF2016: 11.862; D1. http://www.ncbi.nlm.nih.gov/pubmed/27138769 +Pubmed +DOI
• Sánchez-Ares M, Cameselle-Teijeiro JM, Vázquez-Estévez S, Lázaro-Quintela M, Vázquez-Boquete Á, Afonso-Afonso FJ, Casal-Rubio J, González-Piñeiro AL, Rico-Rodríguez Y, Fírvida-Pérez JL, Ruíz-Bañobre J, Couso E, Santomé L, Pérez-Becerra R, García-Campelo R, Amenedo M, Azpitarte-Raposeiras C, Antúnez J, Abdulkader I. Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia). Oncol Lett. 2016 Aug;12(2):1403–7. PMID: 27446444. DOI: 10.3892/ol.2016.4788. IF2016: 1.390; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27446444 +Pubmed +DOI
• Valentín F, Guarinos C, Juárez M, Rodríguez-Soler M, Serradesanferm A, Rodriguez-Moranta F, Nicolas-Perez D, Bujanda L, Herraiz M, De-Castro L, Fernández-Bañares F, Herreros-de-Tejada A, Martínez F, Aguirre E, Ferrández Á, Díaz-Tasende J, Piñol V, Paya A, Egoavil C, Alenda C, Castells A, Jover R, Cubiella J. Endoscopic surveillance in patients with multiple (10-100) colorectal polyps. Endoscopy. 2016 Jan;48(1):56–61. PMID: 26165738. DOI: 10.1055/s-0034-1392515. IF2016: 5.444; D1. http://www.ncbi.nlm.nih.gov/pubmed/26165738 +Pubmed +DOI
• Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A. EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10). Cancer Manag Res. 2016 Feb;8:11–20. PMID: 26893581. DOI: 10.2147/CMAR.S85173. IF2016: 3.851; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26893581 +Pubmed +DOI
• Vera R, Dotor E, Feliu J, González E, Laquente B, Macarulla T, Martínez E, Maurel J, Salgado M, Manzano JL. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016). Clin Transl Oncol. 2016 Dec;18(12):1172–8. PMID: 27896637. DOI: 10.1007/s12094-016-1586-x. IF2016: 2.353; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27896637 +Pubmed +DOI
• Williams TGS, Cubiella J, Griffin SJ, Walter FM, Usher-Smith JA. Risk prediction models for colorectal cancer in people with symptoms: a systematic review. BMC Gastroenterol. BMC Gastroenterology; 2016 Jun;16(1):63. PMID: 27296358. DOI: 10.1186/s12876-016-0475-7. IF2016: 2.212; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27296358 +Pubmed +DOI

Capítulos de libro

• Crespo-Casal M. Infecciones causadas por el virus del herpes simple y de la Varicela-Zóster. In: Rozman Borstnar C, Cardellach Lo?pez F (eds.). Farreras-Rozman Medicina Interna (XVIII Edición). 18th ed. Barcelona: Elsevier Health Sciences Spain; 2016. p. 2313–6. ISBN: 978-84-9022-996-5. http://media.axon.es/pdf/109425.pdf Enlace

Guías de Práctica Clínica

• Lamelo-Alfonsín F, Charlín-Pato G, Fernández-Calvo O. Fisterra Guías Clínicas: Nutrición en el paciente con cáncer. 2016. Revisión 2016. http://www.fisterra.com/guias-clinicas/nutricion-paciente-con-cancer/ Enlace

Artículos Científicos

• Anido Herranz U, Fernández Calvo O, Afonso Afonso FJ, Rodríguez Martínez de Llano S, Lázaro Quintela M, León Mateos L, Vázquez Estévez S, Antón Aparicio LM. Radium-223 dichloride: a new paradigm in the treatment of prostate cancer. Expert Rev Anticancer Ther. 2015 Mar;15(3):339–48. PMID: 25555355. DOI: 10.1586/14737140.2015.999045. IF2015: 2.094; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25555355 +Pubmed +DOI
• Bujanda L, Sarasqueta C, Castells A, Pellisé M, Cubiella J, Gil I, Cosme A, Arana-Arri E, Mar I, Idigoras I, Portillo I, EUSCOLON Study Investigators. Colorectal cancer in a second round after a negative faecal immunochemical test. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):813–8. PMID: 25856688. DOI: 10.1097/MEG.0000000000000366. IF2015: 2.093; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25856688 +Pubmed +DOI
• Castro I, Estevez P, Cubiella J, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Cid E, Gil I, Larzabal M, Bujanda L, Castells A, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci. 2015 May;60(5):1424–32. PMID: 25407805. DOI: 10.1007/s10620-014-3434-6. IF2015: 2.516; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25407805 +Pubmed +DOI
• Cubiella J. Quo vadis, NICE? Rev Esp Enferm Dig. 2015 May;107(5):253–4. PMID: 25952798. IF2015: 1.455; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25952798 +Pubmed
• Fernández López MT, Fidalgo Baamil O, López Doldán C, Bardasco Alonso ML, de Sas Prada MT, Lagoa Labrador F, García García MJ, Mato Mato JA. [Prevalence of malnutrition in not critically ill older inpatients]. Nutr Hosp. 2015 Jun;31(6):2676–84. PMID: 26040381. DOI: 10.3305/nh.2015.31.6.8989. IF2015: 1.497; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26040381 +Pubmed +DOI
• Otero-Estévez O, De Chiara L, Rodríguez-Berrocal FJ, Páez de la Cadena M, Cubiella J, Castro I, Gonzalez-Mao C, Hernández-Ramírez V, Martínez-Zorzano VS. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test. Br J Cancer. 2015 Jan;112(2):375–81. PMID: 25461801. DOI: 10.1038/bjc.2014.605. IF2015: 5.569; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25461801 +Pubmed +DOI
• Otero-Estévez O, De Chiara L, Rodríguez-Girondo M, Rodríguez-Berrocal FJ, Cubiella J, Castro I, Hernández V, Martínez-Zorzano VS. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening. Sci Rep. 2015 Aug;5:13030. PMID: 26264519. DOI: 10.1038/srep13030. IF2015: 5.228; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26264519 +Pubmed +DOI
• Quintero-Aldana G, Jorge M, Grande C, Salgado-Fernández M, Gallardo E, Varela S, López C, Villanueva MJ, Fernández A, Alvarez E, González P, Castellanos J, Casal J, López R, Campos Balea B. Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer. Cancer Chemother Pharmacol. 2015 Oct;76(4):731–7. PMID: 26242221. DOI: 10.1007/s00280-015-2839-z. IF2015: 2.824; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26242221 +Pubmed +DOI
• Salgado Fernández M, Pérez Hoyos MT, Díaz de Corcuera I, Vidal Arbués A, García de la Torre M. Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program. Expert Opin Drug Saf. 2015 Aug;14(8):1171–9. PMID: 26076885. DOI: 10.1517/14740338.2015.1057495. IF2015: 2.896; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26076885 +Pubmed +DOI
• Sastre J, Díaz-Beveridge R, García-Foncillas J, Guardeño R, López C, Pazo R, Rodriguez-Salas N, Salgado M, Salud A, Feliu J. Clinical guideline SEOM: hepatocellular carcinoma. Clin Transl Oncol. 2015 Dec;17(12):988–95. PMID: 26607931. DOI: 10.1007/s12094-015-1451-3. IF2015: 2.075; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26607931 +Pubmed +DOI
• Turnes J, Díaz R, Hernandez-Guerra M, Gómez M, Castells L, Bustamante J, Espinosa MD, Fernández-Castroagudín J, Serrano T, Rendón P, Andrade R, Salgado M, Arenas J, Vergara M, Sala M, Polo BA, Granizo IM, Gonzálvez ML, Viudez A. [Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain]. Gastroenterol Hepatol. 2015 Apr;38(4):263–73. PMID: 25583146. DOI: 10.1016/j.gastrohep.2014.11.001. IF2015: 0.800; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25583146 +Pubmed +DOI
• Vázquez S, Villanueva M, Fírvida J, Campos B, Lázaro M, Huidobro G, Areses M del, Fernández N, Covela M, Casal J. Erlotinib as Second-Line Therapy for Patients with Advanced Non-Small-Cell Lung Cancer and Wild-Type EGFR Tumors. J Anal Oncol. 2015 Sep;4(3):94–101. DOI: 10.6000/1927-7229.2015.04.03.1. IF2015: N/A. http://www.lifescienceglobal.com/journals/journal-of-analytical-oncology/volume-4-number-3/89-abstract/jao/1769-abstract-erlotinib-as-second-line-therapy-for-patients-with-advanced-non-small-cell-lung-cancer-and-wild-type-egfr-tumors +DOI
• Vega P, Valentín F, Cubiella J. Colorectal cancer diagnosis: Pitfalls and opportunities. World J Gastrointest Oncol. 2015 Dec;7(12):422–33. PMID: 26690833. DOI: 10.4251/wjgo.v7.i12.422. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26690833 +Pubmed +DOI

Artículos Científicos

• Brea-Fernández AJ, Cameselle-Teijeiro JM, Alenda C, Fernández-Rozadilla C, Cubiella-Fernández J, Clofent J, Reñé JM, Anido U, Milá M, Balaguer F, Castells A, Castellvi-Bel S, Jover R, Carracedo A, Ruiz-Ponte C. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families. Clin Genet. 2014 Jun;85(6):583–8. PMID: 23837913. DOI: 10.1111/cge.12232. IF2014: 3.931; Q2. http://www.ncbi.nlm.nih.gov/pubmed/23837913 +Pubmed +DOI
• Bujanda L, Sarasqueta C, Lanas Á, Quintero E, Cubiella J, Hernández-Ramírez V, Morillas JD, Perez-Fernández T, Salas D, Andreu M, Carballo F, Bessa X, Portillo I, Jover R, Balaguer F, Cosme A, Castells A, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Effect of oral anticoagulants on the outcome of faecal immunochemical test. Br J Cancer. 2014 Mar;110(5):1334–7. PMID: 24496455. DOI: 10.1038/bjc.2014.38. IF2014: 4.836; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24496455 +Pubmed +DOI
• Casal Rubio J, Fírvida-Pérez JL, Lázaro-Quintela M, Barón-Duarte FJ, Alonso-Jáudenes G, Santomé L, Afonso-Afonso FJ, Amenedo M, Huidobro G, Campos-Balea B, López-Vázquez MD, Vázquez S. A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. Cancer Chemother Pharmacol. 2014 Mar;73(3):451–7. PMID: 24352251. DOI: 10.1007/s00280-013-2370-z. IF2014: 2.769; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24352251 +Pubmed +DOI
• Castells A, Quintero E, Álvarez C, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Hijona E, Portillo I, Enríquez-Navascués JM, Hernández V, Martínez-Turnes A, Menéndez-Villalva C, González-Mao C, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Sopeña F, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pozo À, Pellisé M, Balaguer F, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M, Bessa X, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1708-16.e4. PMID: 24681078. DOI: 10.1016/j.cgh.2014.03.022. IF2014: 7.896; D1. http://www.ncbi.nlm.nih.gov/pubmed/24681078 +Pubmed +DOI
• Castro I, Cubiella J, Rivera C, González-Mao C, Vega P, Soto S, Hernandez V, Iglesias F, Teresa Alves M, Bujanda L, Fernández-Seara J. Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Int J Cancer. 2014 Jan;134(2):367–75. PMID: 23818169. DOI: 10.1002/ijc.28353. IF2014: 5.085; Q1. http://www.ncbi.nlm.nih.gov/pubmed/23818169 +Pubmed +DOI
• Cubiella J, Castro I, Hernandez V, González-Mao C, Rivera C, Iglesias F, Alves MT, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Estevez P, Cid E, Herreros-Villanueva M, Portillo I, Bujanda L, Fernández-Seara J. Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening. United Eur Gastroenterol J. 2014 Dec;2(6):522–9. PMID: 25452848. DOI: 10.1177/2050640614553285. IF2014: 2.253; Q3. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4245302&tool=pmcentrez&rendertype=abstract +Pubmed +DOI
• Cubiella J, Castro I, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Martínez-Ares D, Estevez P, Cid E, Herreros-Villanueva M, Portillo I, Bujanda L, Fernández-Seara J, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1884–92. PMID: 24962836. DOI: 10.1158/1055-9965.EPI-13-1346. IF2014: 4.125; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24962836 +Pubmed +DOI
• Cubiella-Fernández J, Salve M, Díaz-Ondina M, Vega P, Alves MT, Iglesias F, Sánchez E, Macía P, Blanco I, Bujanda L, Fernández-Seara J. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria. Colorectal Dis. 2014 Aug;16(8):O273-82. PMID: 24456168. DOI: 10.1111/codi.12569. IF2014: 2.351; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24456168 +Pubmed +DOI
• Fernandez-Plana J, Pericay C, Quintero G, Alonso V, Salud A, Mendez M, Salgado M, Saigi E, Cirera L, ACROSS Study Group. Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study). BMC Cancer. 2014 Nov;14:865. PMID: 25417182. DOI: 10.1186/1471-2407-14-865. IF2014: 3.362; Q2. http://www.ncbi.nlm.nih.gov/pubmed/25417182%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4251687 +Pubmed +DOI
• Gomez-Martín C, Lopez-Rios F, Aparicio J, Barriuso J, García-Carbonero R, Pazo R, Rivera F, Salgado M, Salud A, Vázquez-Sequeiros E, Lordick F. A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond. Cancer Lett. 2014 Aug;351(1):30–40. PMID: 24943493. DOI: 10.1016/j.canlet.2014.05.019. IF2014: 5.621; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24943493 +Pubmed +DOI
• Guarinos C, Juárez M, Egoavil C, Rodríguez-Soler M, Pérez-Carbonell L, Salas R, Cubiella J, Rodríguez-Moranta F, De-Castro L, Bujanda L, Serradesanferm A, Nicolás-Pérez D, Herráiz M, Fernández-Bañares F, Herreros-de-Tejada A, Aguirre E, Balmaña J, Rincón M-L, Pizarro A, Polo-Ortiz F, Castillejo A, Alenda C, Payá A, Soto J-L, Jover R. Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. Clin Cancer Res. 2014 Mar;20(5):1158–68. PMID: 24470512. DOI: 10.1158/1078-0432.CCR-13-1490. IF2014: 8.722; D1. http://www.ncbi.nlm.nih.gov/pubmed/24470512 +Pubmed +DOI
• Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, Castro I, de Castro L, Vega P, Hermo JA, Macenlle R, Martínez-Turnes A, Martínez-Ares D, Estevez P, Cid E, Vidal MC, López-Martínez A, Hijona E, Herreros-Villanueva M, Bujanda L, Rodriguez-Prada JI, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J Gastroenterol. 2014 Jan;20(4):1038–47. PMID: 24574776. DOI: 10.3748/wjg.v20.i4.1038. IF2014: 2.369; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24574776 +Pubmed +DOI
• Luque M, Arranz F, Cueva JF, de Juan A, García-Teijido P, Calvo L, Peláez I, García-Palomo A, García-Mata J, Antolín S, García-Estévez L, Fernández Y. Breast cancer management in the elderly. Clin Transl Oncol. Springer Milan; 2014 Apr;16(4):351–61. PMID: 24085574. DOI: 10.1007/s12094-013-1113-2. IF2014: 2.077; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24085574 +Pubmed +DOI
• Salas D, Vanaclocha M, Ibáñez J, Molina-Barceló A, Hernández-Ramírez V, Cubiella J, Zubizarreta R, Andreu M, Hernández C, Pérez-Riquelme F, Cruzado J, Carballo F, Bujanda L, Sarasqueta C, Portillo I, de la Vega-Prieto M, Morillas JD, Valentín V, Lanas A, Quintero E, Castells A. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. Cancer Causes Control. 2014 Aug;25(8):985–97. PMID: 24859111. DOI: 10.1007/s10552-014-0398-y. IF2014: 2.735; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24859111 +Pubmed +DOI

Capítulos de libro

• Cubiella-Fernández J, Salgado M. Tumores del intestino delgado. In: Castells i Garangou A, Balaguer Prunés F (eds.). Cáncer digestivo: patogenia, diagnóstico, tratamiento y prevención. 1st ed. Barcelona: Elsevier; 2014. p. 35–49. ISBN: 9788490226834. https://tienda.elsevier.es/cancer-digestivo-patogenia-diagnostico-tratamiento-y-prevencion-9788490226834.html Enlace